Novartis India Ltd.
| BSE: 500672 | Sector: Health care |
| NSE: NOVARTIND | ISIN Code: INE234A01025 |
| BSE 00:00 | 13 Jul | 566.65 |
5.85 (1.04%) |
OPEN
564.85 |
HIGH
570.00 |
LOW
559.60 |
| NSE 05:30 | 01 Jan | Novartis India Ltd |
| OPEN | 564.85 |
| PREVIOUS CLOSE | 560.80 |
| VOLUME | 8131 |
| 52-Week high | 780.00 |
| 52-Week low | 420.05 |
| P/E | 138.55 |
| Mkt Cap.(Rs cr) | 1,400 |
| Buy Price | 566.65 |
| Buy Qty | 44.00 |
| Sell Price | 574.10 |
| Sell Qty | 24.00 |
Novartis India Ltd. (NOVARTIND) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 499.65 | 1.26 | 512.55 | 315.20 | 119881.02 |
| Dr Reddy's Labs | 3898.60 | -0.18 | 4189.35 | 2352.00 | 64810.33 |
| Divi's Lab. | 2235.25 | 1.45 | 2537.70 | 1466.95 | 59334.71 |
| Cipla | 638.15 | -0.08 | 696.00 | 356.75 | 51450.84 |
| Biocon | 414.60 | 0.07 | 455.00 | 211.30 | 49752.00 |
| Aurobindo Pharma | 809.20 | -1.41 | 828.45 | 281.15 | 47411.03 |
| Torrent Pharma. | 2359.90 | 0.30 | 2679.45 | 1453.00 | 39934.23 |
| Lupin | 869.30 | 0.99 | 955.85 | 505.00 | 39387.98 |
| Cadila Health. | 358.20 | 0.55 | 383.65 | 206.45 | 36668.93 |
| Abbott India | 15522.95 | 0.08 | 18569.00 | 8299.80 | 32986.27 |
| Piramal Enterp. | 1432.20 | -1.17 | 2039.27 | 608.00 | 32303.27 |
| Alkem Lab | 2404.70 | -0.68 | 2882.10 | 1662.30 | 28748.19 |
| Glaxosmi. Pharma | 1506.55 | 1.31 | 1745.00 | 1046.40 | 25522.46 |
| Ipca Labs. | 1642.15 | -1.20 | 1821.00 | 844.20 | 20748.57 |
| Apollo Hospitals | 1431.95 | 2.09 | 1814.00 | 1047.45 | 19921.29 |
| Pfizer | 4133.20 | 1.05 | 5172.95 | 2797.50 | 18909.39 |
| Alembic Pharma | 943.90 | 0.34 | 984.00 | 436.10 | 17792.52 |
| Sanofi India | 7617.15 | -0.10 | 8528.45 | 5610.00 | 17542.30 |
| Syngene Intl. | 435.65 | -1.04 | 474.75 | 201.65 | 17426.00 |
| Dr Lal Pathlabs | 1886.55 | 6.03 | 1918.05 | 1037.60 | 15722.51 |
Quick Links for Novartis India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
